Dolutegravir And Lamivudine 58437-0027-00
- Manufacturer
- Glaxosmithkline Llc
- Dosage Form
- Tablet, Film Coated
- Product Type
- Drug For Further Processing
- Marketing Start
- January 1, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dolutegravir Sodium | 50 mg/1 |
| Lamivudine | 300 mg/1 |
Selected Package
58437-0027-00Selected38550 TABLET, FILM COATED in 1 DRUM (58437-027-00)